GPC1 and prostate cancer: We found that serum levels of GPC1 can distinguish between PDAC and gallbladder carcinoma, colorectal carcinoma, gastric carcinoma, and prostate cancer, but could not differentiate PDAC from hepatocellular carcinoma and cholangiocarcinoma.